Quantitative evaluation of somatostatin receptor subtype 2 expression in sporadic colorectal tumor and in the corresponding normal mucosa

Clinical Cancer Research

Volumn 8, Issue 2, 2002, Pages 419-427

  Casini Raggi, Claudia ^a   Calabrò, Antonino ^a   Renzi, Daniela ^a   Briganti, Vittorio ^a   Cianchi, Fabio ^a   Messerini, Luca ^a   Valanzano, Rosa ^a   Cameron Smith, Michela ^a   Cortesini, Camillo ^a   Tonelli, Francesco ^a   Serio, Mario ^a   Maggi, Mario ^a   Orlando, Claudio ^a  

^a UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CARCINOEMBRYONIC ANTIGEN; MESSENGER RNA; PENTETREOTIDE IN 111; RECEPTOR SUBTYPE; SOMATOSTATIN RECEPTOR;

ADULT; AGED; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN TISSUE; IN SITU HYBRIDIZATION; INTESTINE MUCOSA; MAJOR CLINICAL STUDY; MALE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SCINTIGRAPHY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY;

AGED; AGED, 80 AND OVER; CARCINOEMBRYONIC ANTIGEN; COLON; COLORECTAL NEOPLASMS; FEMALE; HUMANS; IN SITU HYBRIDIZATION; MALE; MIDDLE AGED; MUCOUS MEMBRANE; RECEPTORS, SOMATOSTATIN; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0036187843     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Cancer statistics, 2000
2. Adjuvant chemotherapy for colon cancer
3. Molecular markers are predictors of recurrence and survival in patients with Dukes B and Dukes C colorectal adenocarcinoma
4. Somatostatin receptors
5. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by SSTR2 and SST5 somatostatin receptors through different mechanisms
6. Differential expression of five somatostatin receptor subtypes, SSTR1-5, in the CNS and peripheral tissue
7. In situ radiotherapy with 111In-pentetreotide. State of the art and perspectives
8. The binding of bombesin and somatostatin and their analogs to human colon cancers
9. High density of somatostatin receptors in veins surrounding human cancer tissue: Role in tumor-host interaction
10. Somatostatin receptors in human colorectal cancer
11. Loss of sst2 somatostatin receptor gene expression in human pancreatic and colorectal cancer
12. Somatostatin receptor subtype mRNA expression in human colorectal cancer and normal colonic mucosae
13. No loss of sst receptors gene expression in advanced stages of colorectal cancer
14. Increased expression of the mRNA encoding the somatostatin receptor subtype five in human colorectal adenocarcinoma
15. Quantitative determination of sst2 gene expression in neuroblastoma tumor predicts patient outcome
16. Somatostatin analogs in oncology: A look to the future
17. Cancer chemotherapy based on targeting of cytotoxic peptide conjugates to their receptors on tumors
18. Synthesis and biological evaluation of cytotoxic analogs of somatostatin containing doxorubicin or its intensely potent derivative, 2-pyrrolinodoxorubicin
19. In situ radiotherapy with 111In-pentetreotide: Initial observations and future directions
20. Peptide receptor imaging and therapy
21. Type-2 somatostatin receptor mRNA levels in breast and colon cancer determined by a quantitative RT-PCR assay based on dual label fluorogenic probes and the Taqman technology
22. Imaging of somatostatin receptors by indium-111-pentetreotide correlates with quantitative determination of somatostatin receptor type 2 gene expression in neuroblastoma tumors
23. WHO. Histological typing of intestinal tumors
24. Character of the invasive margin in colorectal cancer. Does it improve prognostic information of Dukes Staging?
25. In situ hybridization for procollagen types 1, III, and IV mRNA in normal and fibrotic rat liver: Evidence for predominant expression in non-parenchymal liver cells
26. Expression of epidermal growth factor, transforming growth factor-α and their receptor in the human esophagus
27. Somatostatin binding in normal and malignant human gastrointestinal mucosa
28. Somatostatin receptors in malignant tissues
29. Somatostatin inhibits both in vitro and in vivo carcinoembryonic antigen secretion by human colon cancer
30. Effects of new somatostatin analogues on the cell proliferation of colonic crypts and colonic cancer in rats
31. Inhibitory effect of the somatostatin analogue SMS 201.995 and cytokines on the proliferation of human colon adenocarcinoma cell lines
32. The somatostatin receptor subtype 2 is expressed in normal and tumoral tissues
33. Treatment of liver metastases of human colon cancers in nude mice with somatostatin analogue RC-160
34. Somatostatin receptors-dependent growth inhibition of liver metastases by octreotide
35. The role of somatostatin and its analogues in the diagnosis and treatment of tumors
36. 125I-Tyr3]octreotide: The Rotterdam experience with more than 1000 patients
37. A phase III evaluation of a somatostatin analogue (octreotide) in the treatment of patients with asymptomatic advanced colon carcinoma
38. Octreotide reduces the kinetic index, proliferating cell nuclear antigen-maximum proliferative index, in patients with colorectal cancer
39. A randomised trial of octreotide vs best supportive care only in advanced gastrointestinal cancer patients refractory to chemotherapy
40. The effect of long acting somatostatin analogue SMS 201.995 therapy on tumour kinetic measurements and serum tumour marker concentrations in primary rectal cancer
41. Treatment of patients with metastatic pancreatic and gastrointestinal tumours with the somatostatin analogue Sandostatin: A phase II study including endocrine effects
42. Octreotide has no effect on advanced colon cancer
43. Are carcinoembryonic antigen levels of value in the curative management of colorectal cancer?
44. College of American Pathologists Conference XXXV: Solid tumor prognostic factors-which, how and so what? Summary document and recommendations for implementation
45. 2000 Update of recommendations for the use of tumor markers in breast and colorectal cancer: Clinical practice guidelines of the American Society of Clinical Oncology
46. Recommended colorectal cancer surveillance guidelines by the American Society of Clinical Oncology
47. Detection of colonic cells in peripheral blood of colorectal cancer patients by means of reverse transcriptase and polymerase chain reaction
48. American Joint Committee on cancer prognostic factors consensus conference: Colorectal Working Group